Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,412	5,280	3,348	2,186	2,097	3,039
Market Cap Growth	36.52%	57.69%	53.13%	4.24%	-30.98%	119.78%
Enterprise Value	8,157	4,739	2,933	1,787	1,603	2,598
Last Close Price	82.65	50.39	32.48	20.31	19.80	26.16
PE Ratio	91.98	37.78	31.74	21.59	18.64	28.67
Forward PE	106.37	32.11	32.61	19.95	21.01	32.91
PS Ratio	11.58	7.82	6.94	5.44	5.73	8.59
PB Ratio	13.75	7.77	6.61	4.36	5.58	5.81
P/TBV Ratio	13.73	7.77	6.61	4.36	5.58	5.81
P/FCF Ratio	53.19	26.95	26.38	18.23	12.53	20.16
P/OCF Ratio	53.10	26.66	26.36	18.17	12.49	20.00
PEG Ratio	-	-	-	-	1.50	-
EV/Sales Ratio	11.01	7.02	6.08	4.45	4.38	7.34
EV/EBITDA Ratio	122.27	34.40	27.08	15.69	12.73	20.18
EV/EBIT Ratio	124.40	34.60	27.34	15.87	12.88	20.26
EV/FCF Ratio	50.01	24.19	23.12	14.90	9.58	17.24
Debt / Equity Ratio	0.01	0.01	0	0.00	0.00	0.01
Debt / EBITDA Ratio	0.09	0.05	0.00	0.01	0.00	0.02
Debt / FCF Ratio	0.04	0.04	0.00	0.01	0.00	0.02
Asset Turnover	0.92	0.92	0.80	0.80	0.74	0.72
Inventory Turnover	1.31	1.08	0.94	0.97	1.07	1.08
Quick Ratio	2.85	3.11	4.05	6.60	5.31	9.86
Current Ratio	3.14	3.35	4.39	6.89	5.61	10.07
Return on Equity (ROE)	16.70%	23.81%	21.05%	23.11%	25.03%	23.70%
Return on Assets (ROA)	5.10%	11.71%	11.13%	13.98%	15.63%	16.29%
Return on Capital (ROIC)	6.38%	14.34%	13.28%	16.01%	17.25%	17.79%
Return on Capital Employed (ROCE)	10.10%	19.60%	20.80%	22.00%	33.10%	24.50%
Earnings Yield	1.21%	2.67%	3.17%	4.64%	5.36%	3.49%
FCF Yield	1.88%	3.71%	3.79%	5.48%	7.98%	4.96%
Buyback Yield / Dilution	-7.55%	-1.55%	3.64%	7.94%	-1.42%	-1.33%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q